FDA Panel Votes on Microbiota-Based Enema Therapy for Recurrent C. Difficile Infection By Brian Park, PharmD Publish Date September 23, 2022
More Batches of Moderna COVID-19 Shots Shipped Amid Reports of Shortages Publish Date September 23, 2022
PENS Device Cleared to Treat Pain Following Cardiac Surgery By Brian Park, PharmD Publish Date September 22, 2022
NIH Study Compares Four Commonly Used Type 2 Diabetes Medications By Brian Park, PharmD Publish Date September 22, 2022
Retevmo Approved for RET-Driven Solid Tumors, NSCLC By Brian Park, PharmD Publish Date September 22, 2022
Diacomit Approved for Younger Patients With Dravet Syndrome By Brian Park, PharmD Publish Date September 22, 2022
Gadopiclenol, a New Macrocyclic Gadolinium-Based Contrast Agent, Gets FDA Approval By Brian Park, PharmD Publish Date September 22, 2022
Performance of COVID-19 Rapid Antigen Tests With Nasal Self-Sampling Examined Publish Date September 22, 2022
Greater PSA Decline Predicts Better 177Lu-PSMA-617 Outcomes in mCRPC By Jody A. Charnow Publish Date September 21, 2022
Rezafungin Gets Priority Review for Candidemia, Invasive Candidiasis By Brian Park, PharmD Publish Date September 21, 2022
Pedmark Approved for Pediatric Cisplatin-Associated Ototoxicity By Brian Park, PharmD Publish Date September 21, 2022
First Generic Versions of Tazorac Gel Get FDA Approval By Brian Park, PharmD Publish Date September 20, 2022
Tucatinib + Trastuzumab Granted Priority Review for HER2-Positive Metastatic Colorectal Cancer By Brian Park, PharmD Publish Date September 20, 2022
